Ben Venue Laboratories, a subsidiary of German Boehringer Ingelheim in the US, has engaged Bank of American Merill Lynch to advise it on a proposed sale of its sterile injectable drugs business.
Novartis
Breaking News
French investment firm Wendel and Nordic Capital are the remaining bidders for Germany's medical patch maker LTS Lohmann. The acquisition deal could bring in EUR1.2 billion to the company owned by Novartis, BWK and German tycoon Dietmar Hopp.
Novartis told investors that it will be holding a USD 5 billion share buyback in the next two years. The share repurchase will start immediately, according to the Switzerland-based drugmaker.
Sideris Pharmaceuticals Inc received USD 32 million in capital commitments in its Series A funding round.
Roche Chief Executive Officer Severin Schwan said the founding families of Roche Holding would prefer to remain independent.
Pharmaceutical giants Pfizer, AstraZeneca and Novartis are among those to propose bids for Onyx Pharmaceuticals.
Pharmaceutical companies Novartis and Pfizer showing interest in Onyx
UrgentRx named Michael Valentino as its new member of the board.
Sanofi, Novartis and GSK are in a race to buy Elder Pharma's formulations unit.
1 2
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Tesla Shareholder Asks Judge to Prevent Elon Musk From Moving Pay Fight to Texas to Evade Delaware Ruling
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Illinois Woman, Who Mysteriously Drowned After Giving $1.5 Million to Online Romance Scammers, Knew She'd 'End up Dead'
